Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 5.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,439 shares of the company’s stock after selling 612 shares during the period. Crossmark Global Holdings Inc.’s holdings in Option Care Health were worth $243,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Wellington Management Group LLP grew its position in shares of Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after acquiring an additional 1,328,326 shares during the period. FMR LLC grew its position in shares of Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP grew its position in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after acquiring an additional 599,589 shares during the period. State Street Corp grew its position in shares of Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after acquiring an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans grew its position in shares of Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after acquiring an additional 404,811 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective on the stock. Barrington Research lifted their price objective on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. lifted their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $32.25.

Option Care Health Trading Up 3.6 %

OPCH opened at $31.42 on Tuesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company’s 50 day simple moving average is $24.42 and its two-hundred day simple moving average is $27.83. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The firm has a market capitalization of $5.35 billion, a price-to-earnings ratio of 26.40, a price-to-earnings-growth ratio of 2.11 and a beta of 1.31.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.